Jane Montealegre
Department of Behavioral Science, Division of Cancer Prevention and Population Sciences
About Dr. Jane Montealegre
Present Title & Affiliation
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, TX
Adjunct Associate Professor, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
Education & Training
Degree-Granting Education
| 2011 | The University of Texas School of Public Health, Houston, Texas, US, Epidemiology, Ph.D |
| 2005 | Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, US, Tropical Medicine, MSPH |
| 2004 | Tulane University, New Orleans, Louisiana, US, Ecology and Evolutionary Biology, BS |
Postgraduate Training
| 2019-2019 | Traineeship, Training Institute in Dissemination and Implementation Science in Cancer, National Cancer Institute, Bethesda, Maryland |
| 2011-2013 | Postdoctoral Research Fellowship, Cancer Prevention, The University of Texas School of Public Health, Houston, Texas |
Experience & Service
Academic Appointments
Assistant Professor, Department of Pediatrics-Hematology/Oncology, Baylor College of Medicine, Houston, TX, 2017 - 2023
Instructor, Department of Pediatrics-Hematology/Oncology, Baylor College of Medicine, Houston, TX, 2014 - 2017
Administrative Appointments/Responsibilities
Interim Associate Director, Department of Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2022 - 2023
Assistant Director, Department of Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2019 - 2023
Deputy Director, Department of Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2018 - 2023
Senior Associate for Community Programs in Disparities, Department of Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 2014 - 2018
Other Appointments/Responsibilities
Consultant, Global AIDS Program, U.S. Centers for Disease Control and Prevention-Guatemala, Guatemala City, Guatemala Department, 2010 - 2011
Institutional Committee Activities
Member, Population Science Working Group, 2025 - Present
Member, National Roundtable on Cervical Cancer Steering Committee American Cancer Society, 2025 - Present
Member, CONNECT Texas Colorectal Cancer Screening Coordinating Center Steering Committee, 2023 - Present
Member, Self-Collection Workgroup, 2023 - Present
Member, Cervical Cancer Screening Priority Area Workgroup, 2020 - Present
Chair, Commission on Cancer Standard 8.1 Workgroup: Addressing Barriers to Care, 2016 - Present
Honors & Awards
| 2024 | Leading Mentor Award, MD Anderson Division of Cancer Prevention |
| 2023 | Invited panelist to the White House Gender Policy Council on Cervical Cancer Prevention, The White House Cancer Moonshot |
| 2022 | Global Health Scholar, Baylor College of Medicine |
| 2021 | Young Investigator Award, Department of Pediatrics, Baylor College of Medicine |
| 2017 | Hearst Health Prize for Excellence in Population Health, The Hearst Foundation |
| 2011 | Cancer Prevention and Research Institute of Texas (CPRIT) Postdoctoral Fellowship in Cancer Prevention, The University of Texas School of Public Health |
| 2009 | Dissertation Research Grant, Centers for Disease Control and Prevention |
| 2009 | Student Field Activities Award, The University of Texas School of Public Health |
| 2007 - 2009 | Public Health Traineeship, The University of Texas School of Public Health |
| 2004 - 2005 | Dean's Grant, Tulane University School of Public Health and Tropical Medicine |
| 2004 | Fred P. Kagle Award for Outstanding Research in Biology, Tulane University |
| 2004 | Phi Kappa Phi, National Honors Society |
| 2004 | Summa cum laude, Tulane University |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Sokale, IO, Kuo, DC, Hoppenot, C, Reitzel, LR, Juarez, LH, Hernandez, KJ, Parker, SL, Amos, CI, Daheri, ME, Keene, KR, Montealegre, JR, Thrift, AP. Self-Collection for Primary HPV Testing. Annals of emergency medicine 85(3):249-257, 2025. e-Pub 2025. PMID: 39545880.
- Sokale, IO, Montealegre, JR, Amuta, A, Oluyomi, AO, Thrift, AP. Racial and Ethnic Disparities in Human Papillomavirus Vaccination Among US-Born and Foreign-Born Adults Aged 18 to 26 Years in the United States. Vaccines 13(2), 2025. e-Pub 2025. PMID: 40006645.
- Soto-Salgado, M, González, L, Cruz-Cortés, M, Rivera-Morales, MI, Umpierre, S, Montealegre, JR, Ortiz, AP. Cervical Pap screening among women living with HIV in Puerto Rico and the United States – Medical Monitoring Project, 2018–2021. Gynecologic Oncology Reports 54, 2024. e-Pub 2024. PMID: 39045262.
- Sokale, IO, Thrift, AP, Montealegre, JR, Chido-Amajuoyi, OG, Adekanmbi, V, Oluyomi, AO. Using Geospatial Analysis to Identify Priority Communities for Cervical Cancer Prevention in Texas. AJPM Focus 3(4), 2024. e-Pub 2024. PMID: 39034933.
- Alvarez VHA, Amboree TL, Mitchell P, Badr HJ, Montealegre JR. Nativity Disparities in Colorectal Cancer Screening Among Hispanics in the United States. J Immigr Minor Health 26(4):632-640, 2024. e-Pub 2024. PMID: 38635108.
- Amboree, TL, Montealegre, JR, Parker, SL, Garg, A, Damgacioglu, H, Schmeler, KM, Chiao, EY, Hill, EG, Sonawane, K, Deshmukh, AA, Adsul, P. National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers. JAMA Internal Medicine 184(6):671-679, 2024. e-Pub 2024. PMID: 38683574.
- Amboree, TL, Damgacioglu, H, Sonawane, K, Adsul, P, Montealegre, JR, Deshmukh, AA. Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000–2019. International Journal of Cancer 154(9):1549-1555, 2024. e-Pub 2024. PMID: 38270521.
- Sonawane, K, Zhu, Y, Damgacioglu, H, Garg, A, Graboyes, E, Montealegre, JR, Brownstein, NC, Ford, ME, Roberts, JR, Sterba, KR, Giuliano, AR, Deshmukh, AA. Factors associated with parental human papillomavirus vaccination intentions among adolescents from socioeconomically advantaged versus deprived households. The Lancet Regional Health - Americas 31, 2024. e-Pub 2024. PMID: 38500960.
- Thompson, DI, Callender, C, Dave, JM, Jibaja-Weiss, M, Montealegre, JR. Health equity in action. Cancer Causes and Control 35(2):311-321, 2024. e-Pub 2024. PMID: 37736870.
- Batman, S, Rangeiro, R, Monteiro, EC, Changule, D, Daud, S, Ribeiro, M, Tsambe, E, Bila, C, Osman, N, Carrilho, C, Neves, A, Atif, H, De Jesus, C, Mariano, AA, Moretti-Marques, R, Vieira, MA, Fontes-Cintra, G, Lopes, A, Batware, JC, Luis, E, Grover, S, Baker, E, Fellman, B, Montealegre, JR, Castle, PE, Jeronimo, J, Chiao, EY, Lorenzoni, C, Schmeler, KM, Salcedo, MP. Expanding Cervical Cancer Screening in Mozambique. JCO Global Oncology 9, 2023. e-Pub 2023. PMID: 37824802.
- Sokale, IO, Rosales, O, Montealegre, JR, Oluyomi, AO, Thrift, AP. Trends in Up-To-Date Colorectal Cancer Screening Among U.S. Adults Aged 50–75 Years and Variations by Race/Ethnicity and U.S. Census Bureau Divisions. AJPM Focus 2(1), 2023. e-Pub 2023. PMID: 37789945.
- Spezia-Lindner, NJ, Montealegre, JR, Daheri, ME, Harris, SL, Muldrew, KL, Suarez, MG. Use of fecal immunochemical testing in acute patient care in a safety net hospital system. Journal of Clinical Outcomes Management 28(2):82-89, 2021. e-Pub 2021.
- Montealegre JR, Peckham-Gregory EC, Marquez-Do D, Dillon L, Guillaud M, Adler-Storthz K, Follen M, Scheurer ME. Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecol Oncol 148(2):357-362, 2018. e-Pub 2018. PMID: 29276057.
Selected Presentations & Talks
Regional Presentations
- 2025. Accelerating the Elimination of Cervical Cancer as a Public Health Problem. Invited. Grand Rounds, US.
- 2024. The Power of Elimination: Aligning Efforts to Achieve a Future Free of HPV Cancers in Texas (Keynote Presentation). Invited. Texas Human Papillomavirus Coalition Annual Meeting. Houston, Texas, US.
- 2022. Implementation of a Multi-Level Intervention to Increase Colorectal Cancer Screening and Follow-Up among the Medically Underserved. Invited. Southeastern Colorectal Cancer Consortium Annual Meeting. Irving, TX, US.
- 2022. A Multi-Level Intervention to Increase HPV Vaccination in a Safety Net Health System. Invited. Texas Immunization Conference, US.
- 2022. Communities in Action: HPV Vaccine Equity. Invited. American Cancer Society HPV Forum. Houston, TX, US.
- 2022. It Doesn’t Have to be so Hard: Cervical Cancer Screening in Underserved Populations. Invited. Prevention Grand Rounds. Houston, TX, US.
- 2021. Reasons for HPV Vaccine Missed Opportunities in a Safety Net Health System. Conference. National HPV Conference. Dallas, TX, US.
- 2013. HPV and Cervical Cancer Screening. Invited. Annual Cervical Cancer Summit, US.
National Presentations
- 2025. Using Implementation Science to Accelerate Equity and the Elimination of Cervical Cancer. Invited. American Association for Colposcopy and Cervical Pathology Scientific Meeting. San Diego, CA, US.
- 2025. The Power of Connection. Panelist. Cervical Cancer Summit. Washington, DC, US.
- 2025. Elimination of HPV Cancers Beginning with Cervical: Perspectives from Texas. Invited. 2025 Virtual Annual Meeting of the HPV Vaccination Roundtable of the Southeast, US.
- 2025. HPV Self-Collection Testing for Cervical Cancer Screening. Invited. Delaware Cancer Consortium Meeting, Delaware, US.
- 2024. The Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Trial: Rationale, Design, and Preliminary Results. Invited. Medical University of South Carolina Hollings Cancer Institute, US.
- 2024. Vacunacion Sin Barreras: School-Based HPV Vaccination in the Lower Rio Grande Valley of Texas. Invited. Empowering and Strengthening Community, Culture and Connection to Prevent HPV Cancers, US.
- 2024. Integrating Self-Collection in Safety Net Settings. Invited. National Roundtable on Cervical Cancer Annual Meeting. Atlanta, Georgia, US.
- 2024. Control and Elimination of HPV-Associated Cancers:A Future Within Our Reach. Invited. Rural HPV Vaccination Learning Community, US.
- 2024. Mailed at-home self-sampling for HPV testing increases screening participation among under-screened patients in a U.S. safety net health system: Results of the PRESTIS trial. Conference. American Association for Cancer Research Annual Meeting. San Diego, California, US.
- 2023. The Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Trial: Rationale, Design, and Preliminary Results. Invited. Tampa General Hospital Cancer Institute. Tampa, Florida, US.
- 2022. Self-Collection of HPV Testing to Expand Access to Cervical Cancer Screening. Invited. National Cancer Policy Panel: Advancing Progress in Cancer Prevention and Risk Reduction. Washington, DC, US.
- 2022. Using Self-Sample HPV Testing to Increase Cervical Cancer Screening in Safety Net Health Systems. Invited. American College of Epidemiology, ACE in Action Series, US.
- 2021. Adoption and Implementation of School-Based HPV Vaccination in the Lower Rio Grande Valley (RGV) of Texas, USA. Conference. American Society for Colposcopy and Cervical Pathology Scientific Meeting on Anogenital and HPV-Related Diseases, US.
- 2021. Using Every Chance You Get: Cancer Screening and Primary Prevention among Medically Underserved Populations. Invited. Georgetown University. Washington, DC, US.
- 2012. Respondent Driven Sampling for HIV Behavioral Surveillance among Immigrant Populations. Invited. University of Cincinnati. Cincinnati, OH, US.
International Presentations
- 2025. Barriers to cervical cancer screening and experiences with mailed self-collection kits for HPV testing among Asian/Asian American women in a U.S. safety net health system. Conference. Eurogin International Congress. Porto, PT.
- 2024. Predictors of Cervical Cancer Screening Uptake by Modality among Participants in the PRESTIS Trial to Assess Effectiveness of At-Home Self-Collection Kits for HPV Testing. Conference. International Papillomavirus Conference. Edinburgh, GB.
- 2023. Acceptability of Self-Sample HPV Testing among Underscreened Women in a Safety Net Health System. Conference. International Papillomavirus Conference. Washington, US.
- 2023. Perceived barriers to clinic-based cervical cancer screening and motivators for HPV self-sampling during the COVID-19 pandemic. Conference. Eurogin International Congress. Bilbao, ES.
- 2022. Impact of the COVID-19 Pandemic on Participation in a Self-Sample HPV Testing Randomized Trial. Conference. Eurogin International Congress. Dusseldorf, DE.
- 2022. Mailed, At-Home Self-Collection Kits to Increase Cervical Cancer Screening among Underscreened Patients in a Safety Net Health System: Results of the PRESTIS Trial. Conference. Eurogin International Congress. Stockholm, SE.
- 2022. Effectiveness-Implementation Research to Improve Cervical Cancer Screening (Estudio de efectividad- implementacion para mejorar tamizaje de cancer cervical). Invited. Mexican National Public Health Institute 100 Year Anniversary Series, US.
- 2021. HPV Vaccination In a Safety Net Health System During the COVID-19 Pandemic. Conference. Eurogin International Congress, US.
- 2021. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation. Invited. Preinvasive Disease Program, US.
- 2020. Self-Sample HPV Testing for Cervical Cancer Screening in Latin America and the Caribbean (La Auto-Toma de Muestras del VPH para el Tamizaje del Cáncer Cervico-Uterino en Latinoamérica y el Caribe). Invited. ECHO-Latin America (ELA) Program, US.
- 2011. Respondent Driven Sampling among Undocumented Central American Immigrant Women in Houston, Texas. Invited. Oslo, NO.
Formal Peers
- 2025. Introduction to Implementation Science and the Consolidated Framework for Implementation Research. Houston, TX, US.
- 2024. Qualitative Research Methods. Lusaka, ZM.
- 2024. Fundamentos de la Autotoma(Fundamentals of Self-Collection). Visiting. Santiago, CL.
- 2023. Survey Research Methods. Lusaka, ZM.
- 2022. Effectiveness-Implementation Research to Improve Cervical Cancer Screening (Estudio de efectividad- implementacion para mejorar tamizaje de cancer cervical). Invited. Mexico City, MX.
- 2021. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation. Invited, US.
- 2020. Self-Sample HPV Testing for Cervical Cancer Screening in Latin America and the Caribbean (La Auto-Toma de Muestras del VPH para el Tamizaje del Cáncer Cervico-Uterino en Latinoamérica y el Caribe). Invited, US.
- 2020. Self-Sample HPV Testing to Increase Cervical Cancer Screening Participation in Vulnerable Populations. Invited, US.
- 2011. Respondent Driven Sampling among Undocumented Central American Immigrant Women in Houston, Texas. Invited. Oslo, NO.
Grant & Contract Support
| Date: | 2026 - 2031 |
| Title: | An Opportunistic Multicomponent hrHPV Self-Sampling Intervention to Improve Cervical Cancer Screening and Follow-up Among Safety-Net Hospital Emergency Department Patients: PROMPT Trial |
| Funding Source: | Baylor College of Medicine |
| Role: | Co-PI |
| ID: | FP00026072 |
| Date: | 2026 - 2028 |
| Title: | Improving equity in radiotherapy treatments for patients with breast cancer, including rare breast cancers |
| Funding Source: | Lever for Change |
| Role: | Co-PI |
| ID: | FP00025023 |
| Date: | 2025 - 2029 |
| Title: | Development and Testing a Patient Decision Tool for Cervical Cancer Screening Options |
| Funding Source: | UT HEALTH SCIENCE CTR SAN ANTONIO |
| Role: | Co-PI |
| ID: | RP260013 |
| Date: | 2025 - 2029 |
| Title: | Modeling Approaches in Improve Breast, Cervical, and Colorectal Cancer Screening Among Age-Eligible Women in Texas |
| Funding Source: | University of Texas at Austin |
| Role: | Co-PI |
| ID: | RP260652 |
| Date: | 2025 - 2028 |
| Title: | Development of a Patient Decision Tool for Cervical Cancer Screening Options |
| Funding Source: | UT HEALTH SCIENCE CTR SAN ANTONIO |
| Role: | Co-PI |
| ID: | FP00024088 |
| Date: | 2025 - 2027 |
| Title: | Barriers to Breast Cancer Care Among Women Living with HIV in Zambia |
| Funding Source: | NATIONAL CANCER INSTITUTE |
| Role: | PI |
| ID: | 3K12CA088084-23 |
| Date: | 2025 - 2030 |
| Title: | UPR/MDACC: Partnership for Excellence in Cancer Research (Linked Application 1 of 2) |
| Funding Source: | NATIONAL INSTITUTES OF HEALTH |
| Role: | PI |
| ID: | 2U54CA096300-21A1 |
| Date: | 2024 - 2029 |
| Title: | Implementing HPV Vaccination in HIV Treatment Settings (INVITE) For Young Women Living with HIV in Eswatini |
| Funding Source: | NIH/NCI |
| Role: | PI |
| Date: | 2024 - 2029 |
| Title: | Sample-to-answer HPV DNA nucleic acid test for cervical cancer screening in Mozambique |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| ID: | 1R01HL166413-01 |
| Date: | 2024 - 2029 |
| Title: | Family Eats 2: Hybrid 1 Effectiveness-Implementation Trial |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| Date: | 2024 - 2029 |
| Title: | Implementing HPV Vaccination in HIV Treatment Settings (INVITE) for Young Women and Girls Living with HIV in Eswatini |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 1U01CA294753-01 |
| Date: | 2024 - 2025 |
| Title: | Understanding the impact of heterogeneity in psychosocial factors and social determinants of health on cancer treatment receipt among Zambia women diagnosed with cervical cancer |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | 3R01CA28463-01 |
| Date: | 2024 - 2029 |
| Title: | Expanding Access to Cervical Cancer Screening through Primary HR-HPV Testing and Self-Sampling: A Multi-Component Intervention for Safety Net Health Systems |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP240017 |
| Date: | 2024 - 2028 |
| Title: | Initiative for Innovation and Translation of Point-of-Care Technologies for Equitable Cancer Care in Texas (ITEX)- HPV POC |
| Funding Source: | William Marsh Rice University |
| Role: | Co-PI |
| Date: | 2023 - 2028 |
| Title: | Family Eats 2: Hybrid 1 Effectiveness-Implementation Trial |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| Date: | 2023 - 2024 |
| Title: | Prevención en sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening in the Rio Grande Valley of Texas |
| Funding Source: | MD Anderson COE FUT |
| Role: | PI |
| Date: | 2023 - 2028 |
| Title: | School-Based Human Papillomavirus Vaccination Program In The Rio Grande Valley: Continuation And Expansion In Hidalgo, Cameron, And Willacy Counties |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-PI |
| ID: | PP230043 |
| Date: | 2022 - 2024 |
| Title: | Expanding a pragmatic randomized trial to assess mailed self-sample HPV testing to increase cervical cancer screening participation among Asian immigrant women in a safety net health system |
| Funding Source: | NIH/NIMH |
| Role: | PI |
| ID: | 3R01MD013715-04S2 |
| Date: | 2022 - 2023 |
| Title: | Enhancing Sexual Orientation and Gender Identity Data Collection across the Duncan Cancer Center - Administrative Supplement |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | P30 CA125123-16S1 |
| Date: | 2022 - 2027 |
| Title: | Advancing the Implementation of Evidence-Based Strategies for Tobacco Prevention and HPV Vaccination in Pediatric Safety Net Settings |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP220038 |
| Date: | 2022 - 2024 |
| Title: | The Baylor College of Medicine-MD Anderson-Harris Health Cancer Patient Navigation (CANTO) Collaborative |
| Funding Source: | American Cancer Society |
| Role: | PI |
| Date: | 2022 - 2027 |
| Title: | MD Anderson-Baylor College of Medicine-BU Research Base Consortium (MBRACE) toward Elimination of Cervical Cancer in Women Living with HIV |
| Funding Source: | NIH/NCI |
| Role: | Co-PI |
| Date: | 2022 - 2024 |
| Title: | Examining Racial/Ethnic Differences and Determinants of Self-Sample HPV Testing and Usual Care Cervical Cancer Screening Uptake in a Safety Net Health System - Diversity Supplement to NIH/NIMHD |
| Funding Source: | NIH/NIMH |
| Role: | PI |
| ID: | 3R01MD013715-04S1 |
| Date: | 2021 - 2026 |
| Title: | Strengthening Safety Net Health Systems to Improve Cervical and Colorectal Screening and Follow-Up among the Medically Underserved |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP210007 |
| Date: | 2020 - 2022 |
| Title: | Modifying the Home Environment to Promote and Support Child Obesity Prevention- Administrative Supplement to NCI P30 Cancer Center Support Grants to Support Community Outreach and Engagement (COE) Activities across the Translational Research Continuum |
| Funding Source: | NIH/NCI |
| Role: | PI |
| ID: | P30 CA125123-14S5 |
| Date: | 2019 - 2022 |
| Title: | Expanding a Community Network for Cancer Prevention to Increase HPV Vaccine Uptake and Tobacco Prevention in a Medically Underserved Pediatric Population |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP190051 |
| Date: | 2019 - 2024 |
| Title: | A Randomized Controlled Trial of Mail-Self Stamped HPV Testing to Increase Cervical Cancer Screening Participation Among Minority/Underserved Women in an Integrated Safety Net Healthcare System |
| Funding Source: | NIH/NIMH |
| Role: | PI |
| ID: | R01MD013715 |
| Date: | 2017 - 2022 |
| Title: | Expanding a Community Network for Cancer Prevention to Improve Cervical and Colorectal Screening and Follow-up Among an Urban Medically Underserved Population |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | PP170094 |
| Date: | 2016 - 2022 |
| Title: | Leveraging a Community Network for Cancer Prevention to Increase HPV Vaccine Uptake and Completion among Pediatric Patients in a Safety Net Healthcare Setting |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | PI |
| ID: | P160079 |
| Date: | 2009 - 2011 |
| Title: | Sexual HIV Risk-Related Behaviors among Undocumented Central American Immigrant Women in Houston, Texas (Dissertation Research Grant) |
| Funding Source: | Centers for Disease Control (CDC) |
| Role: | PI |
| ID: | R36 PS001440-01 |
Patient Reviews
CV information above last modified May 16, 2025